02/14/2025
4:41 PM | Madison Avenue Partners, LP (Filed by)
Ovid Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
4:15 PM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
8:18 AM | ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:15 PM | Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:15 PM | Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:15 PM | Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:15 PM | Fitzgerald Kevin Joseph (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:01 PM | EcoR1 Capital, LLC (Filed by)
Ovid Therapeutics (Subject)
| Form SC 13G/A | |
09/11/2024
4:36 PM | ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2024
4:38 PM | ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:57 PM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for OVID and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/13/2024
7:02 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:03 AM | Ovid Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
4:22 PM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
7:04 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
6:10 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
4:19 PM | Ovid Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/14/2024
7:11 AM | Ovid Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
7:03 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:57 PM | Ovid Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:59 PM | Ovid Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
4:00 PM | Ovid Therapeutics (Filer)
| Form ARS | |
03/20/2024
4:22 PM | LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:20 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
7:24 AM | Ovid Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
4:54 PM | Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
4:56 PM | Fitzgerald Kevin Joseph (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
4:57 PM | Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
4:58 PM | LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:00 PM | Ovid Therapeutics (Issuer)
Perone Thomas Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:01 PM | Ovid Therapeutics (Issuer)
Poole Robert Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:03 PM | Ovid Therapeutics (Issuer)
Rona Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:05 PM | Ovid Therapeutics (Issuer)
Tardio Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
